Singapore markets close in 1 hour 47 minutes

Gyre Therapeutics, Inc. (GYRE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
10.88+0.18 (+1.68%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Cash flows from operating activities
Net income
-87,645
-92,933
2,302
23,437
Depreciation & amortisation
1,253
1,114
1,129
1,928
Deferred income taxes
-1,145
-1,160
-838
-
Stock-based compensation
7,292
7,281
13,366
-283.1772
Change in working capital
-1,253
7,458
-7,797
-5,351
Accounts receivable
-
1,398
-7,920
-1,956
Inventory
556
1,747
-879
-2,421
Accounts payable
13
192
-112
-34.8284
Other working capital
11,349
17,306
5,679
12,303
Other non-cash items
82,596
82,787
226
98.8375
Net cash provided by operating activities
18,359
25,892
10,677
20,756
Cash flows from investing activities
Investments in property, plant and equipment
-7,010
-8,586
-4,998
-8,452
Acquisitions, net
-
-1,566
-1,332
-
Purchases of investments
-16,933
-15,735
-7,484
-
Sales/maturities of investments
-
-
0
239.7201
Other investing activities
-
-124
-7,291
-
Net cash used for investing activities
-19,332
-19,760
-13,814
-8,191
Cash flows from financing activities
Debt repayment
-
-
-466.2792
-6,703
Dividends paid
-
-
0
0
Net cash used provided by (used for) financing activities
3,158
2,500
0
-6,825
Net change in cash
1,641
8,334
-5,028
5,740
Cash at beginning of period
28,144
25,175
30,203
20,349
Cash at end of period
30,329
33,509
25,175
26,089
Free cash flow
Operating cash flow
18,359
25,892
10,677
20,756
Capital expenditure
-7,010
-8,586
-4,998
-8,452
Free cash flow
11,349
17,306
5,679
12,303